Exploring Aethlon Medical Advances Hemopurifier Study As Final Trial Cohort Nears Completion
Exploring Aethlon Medical Advances Hemopurifier Study As Final Trial Cohort Nears Completion reveals several interesting facts.
- Jim Joyce, Founder and CEO of
- Aethlon Medical
- Aethlon Medical
- Ciro Rinaldi, MD, PhD, Lincoln County Hospital, Lincoln, UK, provides an update on the data from the expansion
- Therapies for transthyretin (ATTR-CM) and immunoglobulin light chain (AL-CM) cardiac amyloidosis are advancing rapidly.
In-Depth Information on Aethlon Medical Advances Hemopurifier Study As Final Trial Cohort Nears Completion
Aethlon Medical Aethlon Medical Dr. Tim Rodell, M.D., CEO and Director at For more info visit www.aethlonmedical.com.
David Sallman, MD, Moffitt Cancer Center, Tampa, FL, briefly highlights the patient
Stay tuned for more updates related to Aethlon Medical Advances Hemopurifier Study As Final Trial Cohort Nears Completion.